Arkolith/Insider Trading/ODTX/Form 4

Dimension Capital II, L.P.

DirectorOdyssey Therapeutics, Inc. (ODTX) · full profile →Form 4 · filed May 12, 2026
Net Buying
Open-Market Buys
$20.0M
Open-Market Sells
$0
Net Open-Market Flow
$20.0M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 8, 2026Conversion(C)1.7M——2.2M
May 8, 2026Buy(P)1.1M$18.00$20.0M3.3M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 8, 2026Conversion(C)16.6M——0

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001012975-26-000417) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML